Search

Coloplast A-S (Class B)

Fermé

575 0.7

Résumé

Variation du prix de l'action

24h

Actuel

Min

571

Max

584.2

Chiffres clés

By Trading Economics

Revenu

70M

875M

Ventes

2M

7B

P/E

Moyenne du Secteur

35.807

90.831

BPA

3.88

Rendement du dividende

4.01

Marge bénéficiaire

12.572

Employés

16,744

EBITDA

2B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.01%

2.20%

Prochains Résultats

6 févr. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

7.5B

130B

Ouverture précédente

574.3

Clôture précédente

575

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 janv. 2026, 19:05 UTC

Principaux Mouvements du Marché

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 janv. 2026, 23:41 UTC

Market Talk

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 janv. 2026, 23:41 UTC

Market Talk

Global Equities Roundup: Market Talk

13 janv. 2026, 23:33 UTC

Market Talk

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 janv. 2026, 23:13 UTC

Acquisitions, Fusions, Rachats

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 janv. 2026, 23:10 UTC

Acquisitions, Fusions, Rachats

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 janv. 2026, 23:03 UTC

Market Talk

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 janv. 2026, 21:50 UTC

Acquisitions, Fusions, Rachats

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 janv. 2026, 21:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

13 janv. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 janv. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 janv. 2026, 21:20 UTC

Acquisitions, Fusions, Rachats

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 janv. 2026, 21:15 UTC

Acquisitions, Fusions, Rachats

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 janv. 2026, 21:08 UTC

Acquisitions, Fusions, Rachats

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 janv. 2026, 20:39 UTC

Market Talk

Silver Settles at Another New High -- Market Talk

13 janv. 2026, 20:21 UTC

Market Talk

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 janv. 2026, 20:17 UTC

Market Talk

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 janv. 2026, 19:08 UTC

Acquisitions, Fusions, Rachats

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 janv. 2026, 19:03 UTC

Résultats

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 janv. 2026, 18:50 UTC

Résultats

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 janv. 2026, 17:54 UTC

Market Talk

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 janv. 2026, 17:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Global Equities Roundup: Market Talk

13 janv. 2026, 17:50 UTC

Market Talk
Acquisitions, Fusions, Rachats

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 janv. 2026, 17:49 UTC

Market Talk

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 janv. 2026, 17:38 UTC

Market Talk

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 janv. 2026, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

13 janv. 2026, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 janv. 2026, 17:20 UTC

Market Talk
Acquisitions, Fusions, Rachats

Basic Materials Roundup: Market Talk

13 janv. 2026, 17:19 UTC

Market Talk

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 janv. 2026, 17:15 UTC

Market Talk

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat